Atlas Trials

A Multicenter Prospective Study Evaluating Concurrent Chemoradiotherapy Following Induction Immunochemotherapy for Esophageal Cancer Based on Dynamic ctDNA Monitoring

Clinical trial NCT06792786 · RECRUITING

Trial details

NCT number
NCT06792786
Sponsor
The Central Hospital of Lishui City
Status
RECRUITING
Phase
Not Applicable
Study type
INTERVENTIONAL
Esophageal CancerctDNA
Start date
2024-12-10
Primary completion
2027-05-31
Enrollment
30

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.